Home › NDC Lookup › Ingredients › Lamotrigine › 51672-4254-06
⚪image loading
(from DailyMed)

Lamotrigine 100 mg Tablet, 30-count — NDC 51672-4254-6 (Billing 51672-4254-06)

by Sun Pharmaceutical Industries, Inc. · 30 TABLET in 1 BOTTLE

This is a package of 30 tablets of Lamotrigine 100 mg Tablet from Sun Pharmaceutical Industries, Inc., marketed since Mar 2026 and currently FDA-listed; retail pharmacies pay about $1.63 per tablet (NADAC). It is this product's only package size.

NDC 51672-4254-06
🏷️ FDA NDC (as labeled) 51672-4254-6 billing pads the package segment with a zero
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 51672-4254-6 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
51672 labeler · 4254 product · 6 package
Package marketed since
Mar 1, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
30 EA per package
Barcode (UPC-A, from the NDC)
3 5167242546 3
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 51672-4254-6
Product NDC 51672-4254
11-digit billing NDC 51672425406
NCPDP billing unit EA — each (per item)
Application # ANDA219677
SPL Set ID 5c3ca706-477a-0d5c-e063-6394a90a1c83
Established class (EPC) Anti-epileptic Agent; Mood Stabilizer
Mechanism of action Dihydrofolate Reductase Inhibitors; Organic Cation Transporter 2 Inhibitors
Physiologic effect Decreased Central Nervous System Disorganized Electrical Activity
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-03-01
Route ORAL
Dosage form TABLET
Substance LAMOTRIGINE
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 065168
GCN 23254
HICL code 007378
Ingredient (HICL) Lamotrigine
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H4
Therapeutic class — intermediate (HIC2) Anticonvulsants
HIC3 code H4B
Therapeutic class — specific (HIC3) Anticonvulsants
AHFS code 28:12.92.00
AHFS class Anticonvulsants, Miscellaneous
FDB label name LAMOTRIGINE ODT 100 MG TABLET
FDB brand name Lamotrigine Odt
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 065168
  • GCN: 23254
  • HICL (First Databank): 007378
  • AHFS class code: 28:12.92.00
Why two NDCs? The FDA registers this code as 51672-4254-6 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 51672-4254-06. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name LAMOTRIGINE ODT 100 MG TABLET Ingredient Lamotrigine
📖 What it is MedlinePlus · NLM

Lamotrigine extended-release (long-acting) tablets are used with other medications to treat certain types of seizures in patients who have epilepsy. All types of lamotrigine tablets (tablets, orally disintegrating tablets, and chewable tablets) other than the extended-release tablets are used alone or with other medications to treat seizures in people who have epilepsy or Lennox-Gastaut syndrome (a disorder that causes seizures and often causes developmental delays). All types of lamotrigine tablets other than the extended-release tablets are also used to increase the time between episodes of...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It treats epilepsy, helping control certain seizure types. Some forms, like tablets, chewables and orally disintegrating tablets, are also used to delay mood episodes in bipolar I...
  • Lamotrigine can cause serious, even life-threatening skin reactions, mostly in the first 2 to 8 weeks. We can't tell which rashes are dangerous, so call your doctor right away abou...
  • Take it by mouth exactly as prescribed, increasing slowly as planned. Skipping ahead raises rash risk. Extended-release tablets are once daily and must be swallowed whole. Food doe...
  • Please don't stop on your own. Stopping suddenly can trigger withdrawal seizures. Your doctor will taper you off over at least 2 weeks.
📖 Read our full Lamotrigine guide →
1
Nutrient depletion considerations

Lamotrigine may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Lamotrigine nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $1.625 $48.75 / 30 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $3.29 $98.76 / 30 tablets
NADAC price history (per ea) — tap or hover for the price & month
May 2026 Jun 2026 Jul 2026 Sep 2026 $1.995 $1.625
▼ Down 14% over the last 5 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
51672-4254-06 You're viewing this Main listing 30 TABLET in 1 BOTTLE 2026-03-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Lamotrigine 100 mg 82009-0132-10 Quallent 1000 tablets $0.049 AB Availability likely save 97%
Subvenite 100 mg 69102-0319-01 OWP 100 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 72888-0026-00 Advagen 1000 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 00904-7008-61 Major 100 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 13668-0047-01 Torrent 100 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 29300-0112-01 Unichem 100 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 68382-0008-01 Zydus 100 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 16714-0195-01 Northstar 100 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 59746-0246-01 Jubilant 100 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 65862-0228-01 Aurobindo 100 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 68084-0319-01 American 100 tablets $0.049 AB Availability likely save 97%
Lamotrigine 100 mg 00115-9941-01 Amneal 30 tablets $1.625 AB Availability likely —
Lamotrigine 100 mg 27241-0185-30 Ajanta 30 tablets $1.625 AB Availability likely —
Lamotrigine 100 mg 43598-0552-30 Dr. 30 tablets $1.625 AB Availability likely —
Lamotrigine 100 mg 49884-0486-11 Par 30 tablets $1.625 AB Availability likely —
Lamotrigine 100 mgthis 51672-4254-06 Sun 30 tablets $1.625 AB Availability likely —
Lamotrigine 100 mg 69918-0370-30 Nordic 30 tablets $1.625 AB Availability likely —
Lamictal 100 mg 00173-0642-55 GlaxoSmithKline 100 tablets $10.918 AB Availability likely +572%
Lamictal Odt 100 mg 00173-0776-02 GlaxoSmithKline 30 tablets $14.636 AB Availability likely +801%
Lamotrigine 100 mg 00115-1528-08 Amneal 10 tablets — AB FDA listed —
Lamotrigine 100 mg 13668-0695-01 Torrent 100 tablets — AB FDA listed —
Lamotrigine 100 mg 46708-0772-10 Alembic 10 tablets — AB FDA listed —
Lamotrigine 100 mg 50228-0321-01 ScieGen 100 tablets — AB FDA listed —
Lamotrigine 100 mg 62332-0772-10 Alembic 10 tablets — AB FDA listed —
Lamotrigine 100 mg 71205-0245-30 Proficient 30 tablets — AB FDA listed —
Lamotrigine 100 mg 46708-0275-30 Alembic 30 tablets — AB FDA listed —
Lamotrigine 100 mg 67877-0165-01 Ascend 100 tablets — AB FDA listed —
Lamotrigine 100 mg 00615-7975-39 NCS 30 tablets — AB FDA listed —
Lamotrigine 100 mg 43063-0203-30 PD-Rx 30 tablets — AB FDA listed —
Lamotrigine 100 mg 71335-0706-01 Bryant 30 tablets — AB FDA listed —
Lamotrigine 100 mg 42291-0367-01 AvKARE 100 tablets — AB FDA listed —
Lamotrigine 100 mg 50090-2130-00 A-S 30 tablets — AB FDA listed —
Lamotrigine 100 mg 62332-0038-30 Alembic 30 tablets — AB FDA listed —
Lamotrigine 100 mg 70518-2343-01 REMEDYREPACK 30 tablets — AB FDA listed —
Lamotrigine 100 mg 55154-2065-00 Cardinal 10 tablets — AB FDA listed —
Lamotrigine 100 mg 67046-0359-03 Coupler 30 tablets — AB FDA listed —
Lamotrigine 100 mg 68071-3607-06 NuCare 60 tablets — AB FDA listed —
Lamotrigine 100 mg 55111-0221-01 Dr.Reddy's 100 tablets — AB FDA listed —
Lamotrigine 100 mg 65841-0684-01 Zydus 100 tablets — AB FDA listed —
Lamotrigine 100 mg 68071-3944-06 NuCare 60 tablets — AB FDA listed —
Lamotrigine 100 mg 68788-7871-03 Preferred 30 tablets — AB FDA listed —
Lamotrigine 100 mg 72789-0206-60 PD-Rx 60 tablets — AB FDA listed —
Lamotrigine 100 mg 51672-4131-00 Sun 100 tablets — AB FDA listed —
Lamotrigine 100 mg 68071-3514-06 NuCare 60 tablets — AB FDA listed —
Lamotrigine 100 mg 82868-0005-30 Northwind 30 tablets — AB FDA listed —
Lamotrigine 100 mg 55154-2330-00 Cardinal 10 tablets — AB FDA listed —
Lamotrigine 100 mg 68788-7223-03 Preferred 30 tablets — AB FDA listed —
Lamotrigine 100 mg 70518-2563-00 REMEDYREPACK 30 tablets — AB FDA listed —
Lamotrigine 100 mg 71335-2328-01 Bryant 30 tablets — AB FDA listed —
Lamotrigine 100 mg 70518-2889-00 REMEDYREPACK 30 tablets — AB FDA listed —
Lamotrigine 100 mg 84677-0033-30 Golden 30 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Mar 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Lamotrigine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSun Pharmaceutical Industries, Inc.
Application holderTARO PHARMACEUTICAL INDUSTRIES LTD
FDA applicationANDA219677 (ANDA)
Labeler code51672
First marketedMar 2026
Product typeHuman Prescription Drug
Portfolio891 products on file

More NDCs from Sun Pharmaceutical Industries, Inc. labeler code 51672

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Lamotrigine — the program that covers self-administered drugs. 15 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Lamotrigine. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$16.58M
Claims incl. refills
1.1M
Beneficiaries
533.3K
Spend / beneficiary
$31.09
Spend / claim
$15.37
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 51672-4253-06 · Sun 51672-4255-06 · Sun →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.